| 08-Jul-2013 | S | Syncom Formulations India Ltd has informed BSE that the Board of Directors of the Company at its meeting held on July 08, 2013, has approved the following businesses subject to further approval of members at their Annual General Meeting:-
Approved pursuant to the provisions of Section 94 of the Companies Act, 1956, and subject to the approval of members at their Annual General Meeting, for sub-division / split of the existing equity shares of the face value of Rs. 10/- (Rs. Ten only) each into 10 (Ten) Equity shares of face value of Rs. 1/- (One only) each.
SUB: Sub Division and Bonus issue of equity shares of Syncom Formulations (India) Ltd. (Scrip Code 524470)
Trading Members of the Exchange ar hereby informed that, Syncom Formulations (India) Ltd. has fixed the Record Date for the purpose of sub division and bonus issue.
DEMATERIALISED SECURITIES - ROLLING SETTLEMENT SEGMENT
COMPANY NAME CODE
Syncom Formulations (India) Ltd.
(524470)
RECORD DATE
20.08.2013
PURPOSE
Sub Division of existing equity shares from every 1 (ONE) equity share of Rs.10/- each into 10 (TEN) equity shares of Re. 1/- each.
SUB-DIVIDED PAID-UP VALUE
Re.1/-
SUB-DIVIDED PAID-UP VALUE & EX-BONUS W.E.F.
19/08/2013 DR-099/2013- 2014
Note :-
i. Trading members are hereby informed that the transactions in the equity shares (physical) of the aforesaid company in the Exit-Route Scheme will be for Re.1/- paid up w.e.f. 19/08/2013.
ii. ISIN No. INE 312C01017 of Rs.10/- paid up will not be valid for transactions done on the Exchange on or after 19/08/2013.
iii. The new ISIN Number for Re.1/- paid up will be informed to the market by a separate notice.
(As Per BSE Notice Dated on 06.08.2013) | 20-Aug-2013 | |
| 13-Aug-2022 | D | Corporate Announcement for recommendation of Dividend @ Rs. 0.03 (3%) per share on the 94,00,00,000 Equity Shares of Rs.1/- each of the Company for the Financial year 2021-22.
| 09-Sep-2022 | |
| 30-May-2017 | D | Syncom Formulations India Ltd has informed BSE that the Board of Directors of the Company at its meeting held on May 30, 2017, inter alia, has recommended a dividend of Rs.0.02 (2%) per equity share of Re. 1/- each for the year 2016-17, subject to approval of the members in the forthcoming AGM.
consent of the members accorded to declare dividend of of Rs. 0.02 (2%) on the equity shares of Rs. 1 each.
(As Per BSE Announcement Dated on 30.09.2017)
| 21-Sep-2017 | |
| 30-May-2016 | D | Syncom Formulations India Ltd has informed BSE that the Board of Directors of the Company at its meeting held on May 30, 2016, inter alia, has recommended a dividend of Rs. 0.02 (2%) per equity share of Re. 1/- each for the year 2015-16, on the total 780652180 equity shares of Re. 1/- each and recommended to pay divided of Rs. 15613043.60 (Rs. One Crore Fifty Six Lakhs Thirteen Thousand Forty Three and Sixty Paise only) which will be paid to all the members/beneficiaries of the Company, subject to approval of member at the forth coming Annual General Meeting of the Company. | 22-Sep-2016 | |
| 30-May-2015 | D | Syncom Formulations India Ltd has informed BSE that the Board of Directors of the Company at its meeting held on May 30, 2015, inter alia, has recommended a dividend of Rs. 0.02 (2%) per equity share of Re.1/- each for the year 2014-15, on the total 78,06,52,180 equity shares of Re. 1/- each and recommended to pay divided of Rs. 1,56,13,043.60 (Rs. One Crore Fifty Six Lakhs Thirteen Thousand Forty Three and Sixty Paise only), subject to approval of member at the forth coming Annual General Meeting of the Company. | 16-Sep-2015 | |
| 30-May-2014 | D | Syncom Formulations India Ltd has informed BSE that the Board of Directors of the Company at its meeting held on May 30, 2014, inter alia, has recommend a dividend of Rs. 0.02 (Two paise) (2%) per equity share of Re. 1/- each for the year 2013-14, on the total 78,06,52,180 equity shares of Re.1/- each and recommended to pay divided of Rs. 1,56,13,044/- only, subject to approval of member at the forthcoming Annual General Meeting of the Company. | 18-Sep-2014 | |
| 04-Jun-2013 | D | Syncom Formulations India Ltd has informed BSE that the Board of Directors of the Company at its meeting held on May 30, 2013, inter alia, has recommend a dividend Rs. 0.60 (Sixty paise) (6%) per equity share of Rs. 10/- each for the year 2012-13, on the total 22304348 equity shares and recommended to pay divided of Rs. 1,33,82,608.80 only which will be paid to all the members/beneficiaries of the Company whose names appears in the register of members and records of the beneficiaries as may be intimated by the Depositories subject to approval of member at the forth coming Annual General Meeting of the Company. | 10-Jul-2013 | |
| 14-Aug-2012 | D | Syncom Formulations India Ltd has informed BSE that the Board of Directors of the Company at its meeting held on August 14, 2012, inter alia, has recommended dividend @ Re. 0.60 (6%) on equity shares of Rs. 10/- each for the year 2011-12 which should be paid to the members subject to the approval of the members during the forthcoming annual general meeting. | 20-Sep-2012 | |
| 11-Aug-2011 | D | Syncom Formulations India Ltd has informed BSE that the Board of Directors of the Company at its meeting held on August 11, 2011, inter alia, has recommended the dividend @ Rs. 0.50 (5%) on the total 2,23,04,348 equity shares of Rs. 10/- each which will be paid to the share holders subject to the approval of members at the next Annual General Meeting. | 22-Sep-2011 | |
| 14-Aug-2010 | D | Syncom Formulations India Ltd has informed BSE that the Board of Directors of the Company at its meeting held on August 14, 2010, inter alia, has recommended the dividend @ Rs. 0.50 (5%) on equity shares of Rs. 10/- each) on total 1,73,34,348 Equity Shares of Rs. 10/- (including 4924000 new shares allotted on June 30, 2010) for the year 2009-10 which will be paid to the share holders subject to the approval of members at the next Annual General Meeting. | 23-Sep-2010 | |
| 28-Aug-2009 | D | Syncom Formulations India Ltd has informed BSE that the Board of Directors of the Company at its meeting held on August 28, 2009, inter alia, has recommended the dividend @ Rs. 0.50 (5%) on equity shares of Rs. 10/- each) on total 9337500 Equity Shares of Rs. 10/- each (including 3112500 new shares allotted on July 10, 2009 under the right issue) for the year 2008-09 which will be paid to the share holders subject to the approval of members at the next Annual General Meeting. | 24-Sep-2009 | |
| 22-Aug-2008 | D | Syncom Formulations India Ltd has informed BSE that the Board of Directors of the Company at its meeting held on August 21, 2008, inter alia, has recommended the dividend @ 5% (Rs 0.50 per equity shares of Rs 10/-each) on Equity Shares of Rs 10/- each for the year 2007-08 which will be paid to the share holders subject to the approval of members at the next Annual General Meeting. | 23-Sep-2008 | |
| 30-Aug-2007 | D | Syncom Formulations India Ltd has informed BSE that the Board of Directors of the Company at its meeting held on August 29, 2007, has considered & recommended the dividend @ 10% (Rs 1.00 per equity shares of Rs 10/-) for the year 2006-07 which will be paid to the shareholders subject to the approval of members at the next Annual General Meeting of the Company. | 20-Sep-2007 | |
| 28-Aug-2006 | D | 15% Dividend | 19-Sep-2006 | |
| 01-May-2006 | D | 15% Dividend | 22-Sep-2005 | |
| 06-Aug-2013 | B | SUB: Sub Division and Bonus issue of equity shares of Syncom Formulations (India) Ltd. (Scrip Code 524470)
Trading Members of the Exchange ar hereby informed that, Syncom Formulations (India) Ltd. has fixed the Record Date for the purpose of sub division and bonus issue.
DEMATERIALISED SECURITIES - ROLLING SETTLEMENT SEGMENT
COMPANY NAME CODE
Syncom Formulations (India) Ltd.
(524470)
RECORD DATE
20.08.2013
PURPOSE
Issue of 5 (FIVE) bonus equity shares of Re. 1/- (ONE) each for every 2 (TWO) equity shares of Re. 1/- (ONE) held.
SUB-DIVIDED PAID-UP VALUE
Re.1/-
SUB-DIVIDED PAID-UP VALUE & EX-BONUS W.E.F.
19/08/2013 DR-099/2013- 2014
Note :-
i. Trading members are hereby informed that the transactions in the equity shares (physical) of the aforesaid company in the Exit-Route Scheme will be for Re.1/- paid up w.e.f. 19/08/2013.
ii. ISIN No. INE 312C01017 of Rs.10/- paid up will not be valid for transactions done on the Exchange on or after 19/08/2013.
iii. The new ISIN Number for Re.1/- paid up will be informed to the market by a separate notice.
(As Per BSE Notice Dated on 06.08.2013) | 20-Aug-2013 | 5:2 |
| 08-May-2009 | R | SUB. :- Rights issue of Syncom Formulations (India) Limited (Scrip Code 524470)
Trading Members of the Exchange are hereby informed that, Syncom Formulations (India) Limited has fixed the Record Date for the purpose of Rights Issue. The transactions in the equity shares of the company should be done on ex-rights basis with effect from the under mentioned date.
COMPANY NAME CODE
Syncom Formulations (India) Limited
(524470)
RECORD DATE
20/05/2009
PURPOSE
Issue of 1 (ONE) Equity Share of Rs.10/- each for cash at a premium of Rs.7/- on rights basis for every 2 (TWO) existing equity share of Rs.10/- each held.
TRANSACTIONS IN EQUITY SHARES ON
Cum-Right basis up to Date & Sett. No.
12/05/2009 DR-026/2009-2010
Ex-Right basis from Date & Sett. No.
13/05/2009 DR-027/2009-2010
The auction in the equity shares of Syncom Formulations (India) Limited in Dematerialised Securities - Rolling Settlement Segment on 13/05/2009, 14/05/2009 and 15/05/2009 will be conducted on cum-right basis. Trading members are, therefore, requested to take abundant precautions while mentioning the rates for offering the equity shares of the said company in auction on the said dates.
The scrip will be in No Delivery from 13/05/2009 (DR-027/2009-2010) to 19/05/2009 (DR-031/2009-2010).
Warrant Exercise Period : Warrant Exercise Period shall be the period commencing after six[6] months from the date of allotment up to forty eight [48]months from the date of allotment. The warrant will get converted on or before a fixed date (i.e. 'Notice Date, the outermost date for conversion') and would be made uniformly in respect of all the warrants outstanding. The Company will fix the Record Date as any time during the Warrant Exercise Period for the purpose of warrant conversion. The conversion of warrants into Equity Shares of the Company will be as per the Warrant Exercise Price as mentioned under the para 'Warrant Exercise Price' provided below.
Warrant Exercise Price : Warrant Exercise Price shall be lower of :
(a) 20% discount to the average six weekly closing prices before the date of the public notice on Designated Stock Exchange; or
(b) 20% discount to average two weekly closing prices before the date of the public notice on the Designated Stock Exchange; or
(c) Rs. 17/- being the Issue price of the Rights Offer. | 20-May-2009 | 1:2 |
| 08-May-2009 | R | SUB. :- Rights issue of Syncom Formulations (India) Limited (Scrip Code 524470)
Trading Members of the Exchange are hereby informed that, Syncom Formulations (India) Limited has fixed the Record Date for the purpose of Rights Issue. The transactions in the equity shares of the company should be done on ex-rights basis with effect from the under mentioned date.
COMPANY NAME CODE
Syncom Formulations (India) Limited
(524470)
RECORD DATE
20/05/2009
PURPOSE
1 (ONE) Detachable warrant for every 1 (ONE) Equity share allotted on rights basis.
TRANSACTIONS IN EQUITY SHARES ON
Cum-Right basis up to Date & Sett. No.
12/05/2009 DR-026/2009-2010
Ex-Right basis from Date & Sett. No.
13/05/2009 DR-027/2009-2010
The auction in the equity shares of Syncom Formulations (India) Limited in Dematerialised Securities - Rolling Settlement Segment on 13/05/2009, 14/05/2009 and 15/05/2009 will be conducted on cum-right basis. Trading members are, therefore, requested to take abundant precautions while mentioning the rates for offering the equity shares of the said company in auction on the said dates.
The scrip will be in No Delivery from 13/05/2009 (DR-027/2009-2010) to 19/05/2009 (DR-031/2009-2010).
Warrant Exercise Period : Warrant Exercise Period shall be the period commencing after six[6] months from the date of allotment up to forty eight [48]months from the date of allotment. The warrant will get converted on or before a fixed date (i.e. 'Notice Date, the outermost date for conversion') and would be made uniformly in respect of all the warrants outstanding. The Company will fix the Record Date as any time during the Warrant Exercise Period for the purpose of warrant conversion. The conversion of warrants into Equity Shares of the Company will be as per the Warrant Exercise Price as mentioned under the para 'Warrant Exercise Price' provided below.
Warrant Exercise Price : Warrant Exercise Price shall be lower of :
(a) 20% discount to the average six weekly closing prices before the date of the public notice on Designated Stock Exchange; or
(b) 20% discount to average two weekly closing prices before the date of the public notice on the Designated Stock Exchange; or
(c) Rs. 17/- being the Issue price of the Rights Offer.
SUB. :- Rights issue of Syncom Formulations (India) Ltd. (Scrip Code 524470)
In continuation of notice no. 20090508-16 dated May 8, 2009, Trading Members are hereby informed that Syncom Formulations (India) Ltd. has now clarified that as per the SEBI observation, Warrant Exercise Period shall be the period commencing after six (6) months from the date of allotment up to Eighteen (18) months from the date of allotment.
In view of the above, the Warrant Exercise Period shall be the period commencing after six (6) months from the date of allotment up to Eighteen (18) months from the date of allotment and not as mentioned in the aforesaid notice.
The other contents of the aforesaid notice remain the same.
Trading Members are requested to take note of it.
(As Per BSE Notice Dated on 12.05.2009) | 20-May-2009 | 1:1 |
| 29-Mar-2024 | BC | Pursuant to Reg 30 of SEBI (LODR), 2015 , WE ARE HEREBY SUBMITTING DISCLOSURE FOR TENSURE COMPLETION OF INDEPENDENT DIRECTORS | 31-Mar-2024 | |
| 06-Feb-2024 | BC | SYNCOM FORMULATIONS (INDIA) LTD.-has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/02/2024 inter alia to consider and approve Pursuant to Regulation 29(1) | 14-Feb-2024 | |
| 27-Oct-2023 | BC | SYNCOM FORMULATIONS (INDIA) LTD.-has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 08/11/2023 inter alia to consider and approve With Reference to Regulation | 08-Nov-2023 | |
| 14-Aug-2023 | BC | AGM 26/09/2023
Notice of 35th AGM of the Company to be held on Tuesday 26th September, 2023 at 3:00 P.M through VC/OAVM.
(As Per BSE Announcement Dated on 29/08/2023)
Pursuant to provisions | 26-Sep-2023 | |
| 16-Aug-2023 | BC | Annual General Meeting | 20-Sep-2023 | |